Economics

Uzbekistan and Japan to Expand Pharmaceutical Cooperation

Uzbekistan and JICA discussed expanding practical cooperation in medicine and pharmaceuticals, including joint projects and technology transfer.

Uzbekistan and the Japan International Cooperation Agency (JICA) are set to broaden their collaboration in the medical and pharmaceutical fields. This development emerged from a meeting held at Uzbekistan's Agency for the Development of the Pharmaceutical Industry in Tashkent.

During the discussion, Abdulla Azizov, Director of the Uzbek Agency, briefed JICA representatives on the ongoing reforms within Uzbekistan's pharmaceutical sector. He highlighted efforts to boost local production, attract foreign investment, foster innovation, and enhance international partnerships. Azizov also shared the agency's successful track record in working with international partners on technology transfer, scientific research, workforce training, and investment ventures.

In response, JICA representatives detailed their existing technical assistance programs in healthcare and pharmaceuticals. They also presented opportunities for professional development for specialists, exchanges of knowledge and expertise, and potential joint projects.

The meeting concluded with an agreement between both parties to expand their practical cooperation, launch joint initiatives, and develop innovative projects within the medical and pharmaceutical sectors.

For additional information on Uzbekistan's healthcare strategy and the agency's sector reforms, an interview with Abdulla Azizov titled "Uzbekistan's Pharma Vision" provides further context. This video features Agency Director Abdulla Azizov discussing Uzbekistan's long-term pharmaceutical vision and international partnerships.

pharmaceutical cooperationtechnology transferuzbekistan-japan relationsinvestment attractionjicahealthcare developmentpharma sector reformsprofessional training